Work Here?
Cerebrae
Work Here?
Financial solutions for healthcare providers and insurers
Cerebrae
Work Here?
Financial solutions for healthcare providers and insurers
About Cerebrae
Industries
Fintech
Financial Services
Healthcare
Company Size
1-10
Company Stage
Series A
Total Funding
$16.5M
Headquarters
San Francisco, California
Founded
2019
Overview
Cerebrae provides financial solutions tailored for the healthcare industry, focusing on helping healthcare providers and insurers manage financial risks and opportunities. Its platform includes tools for pricing, underwriting, contracting, and actuarial analytics, allowing clients to track savings, monitor financial performance, and model return on investment (ROI). The primary clients are those implementing Value-Based Care (VBC) strategies, where payment is based on patient health outcomes rather than service volume. Cerebrae assists these clients in customizing their VBC strategies, evaluating contracts, and assessing financial risks associated with risk-sharing revenue models. Unlike many competitors, Cerebrae operates on a subscription-based model, offering a comprehensive suite of tools that enhance financial operations and risk management. The company's goal is to optimize financial performance for healthcare providers and insurers as they transition to value-based care.
💡 Want to apply to Cerebrae?
You have ways to get a Cerebrae referral from your network.
Get referrals →
Simplify's Take
What believers are saying
- Growing adoption of AI enhances Cerebrae's actuarial analytics capabilities.
- Telehealth data streams improve ROI calculations for value-based care contracts.
- Personalized medicine trends align with Cerebrae's expansion opportunities.
What critics are saying
- Increasing competition may erode Cerebrae's market share.
- Regulatory changes could increase operational costs for platform updates.
- Economic downturns may reduce spending on subscription-based platforms.
What makes Cerebrae unique
- Cerebrae offers a unique platform for managing financial risks in healthcare.
- The platform includes tools for pricing, underwriting, and actuarial analytics.
- Cerebrae collaborates with Sera Prognostics for innovative value-based care solutions.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$16.5M
Above
Industry Average
Funded Over
0 Rounds
Company News
The value created by applying Sera's PreTRM® test and treat strategy enables savings to be shared in an innovative value-based paradigm. SALT LAKE CITY, COPPELL, Texas and SAN MATEO, Calif., Oct. 4, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, Sonrava Health, a national family of health and wellness companies, and Cerebrae, an innovator in pricing and measuring the financial value of care, are collaborating to provide Sera's PreTRM® Test to members of Sonrava Health's employer-sponsored health insurance program. The PreTRM® Test is the only broadly clinically validated, commercially available blood test that provides an early, individual risk assessment for spontaneous preterm birth in asymptomatic, singleton pregnancies. Sera's PreTRM® Test identifies nearly 90% of pregnancies where spontaneous preterm deliveries will occur, enabling earlier proactive intervention designed to improve the well-being of mothers and babies
There are no jobs for Cerebrae right now.
Find jobs on Simplify and start your career today
About Cerebrae
Industries
Fintech
Financial Services
Healthcare
Company Size
1-10
Company Stage
Series A
Total Funding
$16.5M
Headquarters
San Francisco, California
Founded
2019
There are no jobs for Cerebrae right now.
Find jobs on Simplify and start your career today